• Mashup Score: 1

    Colorectal cancer (CRC) is one of the most prevalent and deadly cancers worldwide. Despite recent improvements in treatment and prevention, most of the current therapeutic options are weighted by side effects impacting patients’ quality of life. Better patient selection towards systemic treatments represents an unmet clinical need. The recent multidisciplinary and molecular advancements in the…

    Tweet Tweets with this article
    • Liquid biopsies to monitor and direct cancer treatment in colorectal cancer Read for free: https://t.co/IiuRJ6St9t #Cancergenetics #Tumourbiomarkers https://t.co/U5rA3hHIlh

  • Mashup Score: 1

    Mutations in isocitrate dehydrogenase 2 (IDH2) have been noted to impact cellular differentiation in addition to DNA and histone methylation. However, little is known about the impact of IDH2 mutations on intracellular signaling. Using an isogenic cell line model, we investigated both differentiation and signaling responses in IDH2 mutant cells and show augmented responses to inflammatory immune…

    Tweet Tweets with this article
    • Isocitrate dehydrogenase mutations are associated with altered IL-1β responses in acute myeloid leukemia Read for free with #SharedIt: https://t.co/07TxhEWIIl #Acutemyeloidleukaemia #Cancergenetics #Cellsignalling https://t.co/yb8I7mEhCE

  • Mashup Score: 1

    To investigate clonal hematopoiesis associated gene mutations in vitro and to unravel the direct impact on the human stem and progenitor cell (HSPC) compartment, we targeted healthy, young hematopoietic progenitor cells, derived from umbilical cord blood samples, with CRISPR/Cas9 technology. Site-specific mutations were introduced in defined regions of DNMT3A, TET2, and ASXL1 in CD34+ progenitor…

    Tweet Tweets with this article
    • Modeling clonal hematopoiesis in umbilical cord blood cells by CRISPR/Cas9 Read for free: https://t.co/VjzcwWQ1fi #Cancergenetics #Myelodysplasticsyndrome https://t.co/pdEyOoHTxf

  • Mashup Score: 1

    Li-Fraumeni Syndrome (LFS) is a rare, inherited disorder which leads to a higher risk of certain cancers. NCI has evaluated families with LFS since the syndrome was first recognized in 1969 by Dr. Fred Li and Dr. Joseph Fraumeni. DCEG is now expanding this research through a clinical study and participation in a multi-institutional collaboration.

    Tweet Tweets with this article
    • What a great tribute to giants in #CancerGenetics! https://t.co/bwJEkBmkpS @AndrienneWilson @canpreventmvmt #KnowYourGenes #LFS #CancerPrevention #BetterThanCure #CancerFreeWorld